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Yoichiro Kasahara, Junichi Kotani, Hiroki Sakamoto, Hiroyuki Yokoyama, Hiroshi
Nonogi
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Background: AHA/ACC guidelines recommend prehospital 12-lead ECG for patients
with acute coronary syndromes.However, transmission of prehospital 12-lead ECG to
emergency department (ED) is still not spread and ECG interpretation on the
prehospital and ED is not established. Therefore, we previousely reported the
usefulness of the mobile telemedicine system (MTS) to transmit 12-lead ECG and
other parameters between moving ambulances and physicians in cardiac emergency.
Methods: We set up the MTS on an ambulance in clinical condition. Real time 12-
lead ECG was transmitted together with vital signs and live video during transferring
the patient by the ambulance. We assess the efficacy and usefulness of the MTS for
the triage on 301 cardiovascular emergency cases from June 2008 to May 2011. During
the same period, we had 441 ST-segment elevation myocardial infarction (STEMI)
cases. 50 of these were used this MTS. Then, we compared various data between MTS
(n=50) and non-MTS (n=391) groups with STEMI patients.
Results: We applied the MTS for 301 patients during the transfer to our ED. The mean
time of using this MTS was 14±8 minutes. Of these, there were 84 patients (28%) with
ACS [including 50 STEMI, 6 Non-STEMI, 26 unstable angina, and 2 recent MI] Real-
time 12-lead ECGs were checked in clinical condition and all of them were comparable
to those original ECGs in the ambulance and were useful for the triage to diagnose all
AMI patients before arrival at hospital and for the rapid activation of catheterization
laboratory. Door to balloon time (DBT) was shorter in MTS group (median 82 minutes)
compared with non-MTS group (median 110 minutes) (p<0.001).
Conclusion: Accurate real-time 12-lead ECG transfer is useful for early diagnosis and
the improvement in DBT for STEMI patients.
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Background: The usefulness of a routine invasive strategy has not yet been fully
established among patients with ST-segment elevation myocardial infarction (STEMI)
who have initially been treated with fibrinolytic therapy, despite results of previous
meta-analyses. We conducted this meta-analysis to include newer and larger trials to
determine whether routine percutaneous coronary intervention (PCI) after fibrinolysis
is more beneficial than ischemia-guided PCI in reducing all-cause mortality and
reinfarction while being comparably safe in terms of stroke and major inhospital
bleeding.
Methods: Using the keywords angioplasty, stent, percutaneous coronary intervention,
fibrinolysis, thrombolysis, and myocardial infarction, we included randomized trials
on STEMI patients with >50% stent use. Outcomes included all-cause mortality,
reinfarction, stroke and in-hospital major bleeding. A routine invasive strategy referred
to PCI performed after initial fibrinolysis regardless of clinical course while an
ischemia-guided PCI management referred to PCI only if the post-fibrinolytic period
showed evidence of ischemia.
Results: We identified 7 PCI trials that enrolled 2,560 STEMI patients followed up
from 30 days to 1 year. A routine invasive strategy did not lead to significant reduction
in mortality (relative risk [RR] 0.79, 95% CI 0.56-1.11; P=0.18) but showed a
significant reduction in reinfarction (RR 0.55, 95% CI 0.40-0.77; P=0.0004) compared
with ischemia-guided management. Meanwhile, there were no significant differences
in the risk of stroke (RR 0.96, 95% CI 0.40-2.30; P=0.92) or major bleeding (RR 0.98,
95% CI 0.70-1.36; P=0.89).
Conclusion: Routine PCI after fibrinolytic therapy for STEMI patients does not
significantly reduce mortality but may be considered for its reinfarction benefit, without
increasing stroke or major bleeding. More importantly, an ischemia guided strategy is
acceptable and still relevant in the management of STEMI patients, especially in
situations where catheterization technology is not readily accessible.
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mortality in patients undergoing primary percutaneous coronary interventions
for ST-segment elevation myocardial infarction
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Background: The aims of this study were to determine the interactive effect of
symptom-to-door (STD) time and door-to-balloon (DTB) time on 12-month mortality
in patients undergoing primary percutaneous coronary interventions (PCI) for ST-
segment elevation myocardial infarction (STEMI).
Methods: Between November 2005 and January 2008, 3,108 eligible patients (2,307
men; mean age = 61.8 ± 12.6 years-old) who had an STEMI with an STD time less
than 12 hours and underwent primary PCI were analyzed from the Korea Acute MI
Registry. Patients were stratified into 4 groups based on STD time (<3 versus ≥3 hours)
and DTB time (<90 versus ≥90 minutes). The cutoff points of 3 hours for STD time
and 90 minutes for DTB time were chosen after preliminary analyses of the relation
between STD time and mortality and DTB time and mortality.
Results: The patients with a STD time of <3 hours and DTB time of <90 minutes had
the lowest 12-month mortality (5.9%). Patients with a STD time of <3 hours and DTB
time ≥90 minutes and had significantly greater mortality than patients with an STD
time of <3 hours and DTB time of <90 minutes (hazard ratio [HR] 1.866, 95%
confidence interval [CI] 1.010 to 3.447, p=0.046), as did patients with a STD time of
≥3 hours and DTB time of <90 minutes (adjusted HR 1.957, 95% CI 1.040 to 3.681,
p=0.037) after adjustment for clinical and angiographic variables in Cox proportional
hazards model. The patients with a STD time of ≥3 hours and DTB time of ≥90 minutes
had the highest 12-month mortality compared to patients with an STD time of <3 hours
and DTB time of <90 minutes after adjustment for clinical and angiographic variables
(adjusted HR 2.554, 95% CI 1.388 to 4.700, p=0.003), and after adjustment for clinical,
angiographic, and discharge medications (adjusted HR 2.217, 95% CI 1.015 to 4.843,
p=0.046).
Conclusion: This observational study suggest the combination of short (<3 hours)
OTD time short (<90 minutes) DTB time are associated with the lowest 12-month
mortality in patients with STEMI.
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Background: Management of patients with non-ST-segment elevation myocardial
infarction (STEMI) differs between countries and a gap still exists between guidelines
and current clinical practice. These differences are also observed with time. Therefore
we analyzed temporal trends in treatment and outcomes of STEMI patients in Poland.
Methods: All patients with STEMI (N = 82135), who were registered in the
prospective Polish Registry of Acute Coronary Syndromes from 2004 to 2009 in 452
hospitals scattered throughout Poland were included. Follow-up mortality was obtained
from the government database.
Results: Mean age was stable during 6 years. Significant increase was observed in
percentage of STEMI patients receiving guidelines’ recommended treatment, both
pharmacological and invasive. Median length of stay was significantly has shorter in
2009 compared to 2004. As patients were more aggressively treated (rise reperfusion
therapy) with time, the rates of PCI raised, the rates of thrombolysis declined, and early
as well as 12-month mortality significantly decreased in the subsequent years. Of note
is the increase in major bleedings.
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